The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Structural Simplification of Natural Products
Abstract
Natural products (NPs) are important sources of clinical drugs due to their structural diversity and biological prevalidation. However, the structural complexity of NPs leads to synthetic difficulties, unfavorable pharmacokinetic profiles, and poor drug-likeness. Structural simplification by truncating unnecessary substructures is a powerful strategy for overcoming these limitations and improving the efficiency and success rate of NP-based drug development. Herein, we will provide a comprehensive review of the structural simplification of NPs with a focus on design strategies, case studies, and new technologies. In particular, a number of successful examples leading to marketed drugs or drug candidates will be discussed in detail to illustrate how structural simplification is applied in lead optimization of NPs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Natural products as sources of new drugs from 1981 to 2014
Newman, D. J., & Cragg, G. M. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01055 · Cited by 5,858
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Natural products: A continuing source of novel drug leads
Cragg, G. M., & Newman, D. J. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.02.008 · Cited by 2,906
The re-emergence of natural products for drug discovery in the genomics era
Harvey, A. L., Edrada-Ebel, R., & Quinn, R. J. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4510 · Cited by 2,572
The evolving role of natural products in drug discovery
Koehn, F. E., & Carter, G. T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1657 · Cited by 2,572
The Traditional Medicine and Modern Medicine from Natural Products
Yuan, H., Ma, Q., Ye, L., & Piao, G. (2016) · Molecules · doi:10.3390/molecules21050559 · Cited by 2,434
Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.
Hsiang, Y. H., Hertzberg, R., Hecht, S., & Liu, L. F. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38654-4 · Cited by 2,362
Topoisomerase I inhibitors: camptothecins and beyond
Pommier, Y. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1977 · Cited by 2,277
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain
Ravelli, R. B. G., Gigant, B., Curmi, P. A., Jourdain, I., Lachkar, S., Sobel, A., & Knossow, M. (2004) · Nature · doi:10.1038/nature02393 · Cited by 1,630
Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened
Chen, J. K., Taipale, J., Cooper, M. K., & Beachy, P. A. (2002) · Genes & Development · doi:10.1101/gad.1025302 · Cited by 1,465
Evans, B. E., Rittle, K. E., Bock, M. G., DiPardo, R. M., Freidinger, R. M., Whitter, W. L., Lundell, G. F., Veber, D. F., Anderson, P. S., Chang, R. S. L., et al. (1988) · Journal of Medicinal Chemistry · doi:10.1021/jm00120a002 · Cited by 1,456
Leslie, E. M., Deeley, R. G., & Cole, S. P. C. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.10.012 · Cited by 1,406
FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma
Mann, B. S., Johnson, J. R., Cohen, M. H., Justice, R., & Pazdur, R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-10-1247 · Cited by 1,365
SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
Bauer, W., Briner, U., Doepfner, W., Haller, R., Huguenin, R., Marbach, P., Petcher, T. J., & Pless, J. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90087-x · Cited by 1,331
Counting on natural products for drug design
Rodrigues, T., Reker, D., Schneider, P., & Schneider, G. (2016) · Nature Chemistry · doi:10.1038/nchem.2479 · Cited by 1,250
Protein kinase C isoenzymes: divergence in signal transduction?
Hug, H., & Sarre, T. F. (1993) · Biochemical Journal · doi:10.1042/bj2910329 · Cited by 1,220
Function-Oriented Synthesis, Step Economy, and Drug Design
Wender, P. A., Verma, V. A., Paxton, T. J., & Pillow, T. H. (2008) · Accounts of Chemical Research · doi:10.1021/ar700155p · Cited by 1,204
The vacuolar (H+)-ATPases — nature's most versatile proton pumps
Nishi, T., & Forgac, M. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm729 · Cited by 1,197
THE EVALUATION OF THE ANALGESIC ACTION OF PETHIDINE HYDROCHLORIDE (DEMEROL)
WOOLFE, G., & MACDONALD, A. D. (1944) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09094-9 · Cited by 1,049
Feher, M., & Schmidt, J. M. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0200467 · Cited by 927
Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery
Hann, M. M., Leach, A. R., & Harper, G. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000403i · Cited by 877
Teratogen-Mediated Inhibition of Target Tissue Response to Shh Signaling
Cooper, M. K., Porter, J. A., Young, K. E., & Beachy, P. A. (1998) · Science · doi:10.1126/science.280.5369.1603 · Cited by 848
An analysis of FDA-approved drugs: natural products and their derivatives
Patridge, E., Gareiss, P., Kinch, M. S., & Hoyer, D. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.01.009 · Cited by 831
Leptomycin B Inhibition of Signal-Mediated Nuclear Export by Direct Binding to CRM1
Kudo, N., Wolff, B., Sekimoto, T., Schreiner, E. P., Yoneda, Y., Yanagida, M., Horinouchi, S., & Yoshida, M. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4136 · Cited by 812
Medulloblastoma Growth Inhibition by Hedgehog Pathway Blockade
Berman, D. M., Karhadkar, S. S., Hallahan, A. R., Pritchard, J. I., Eberhart, C. G., Watkins, D. N., Chen, J. K., Cooper, M. K., Taipale, J., Olson, J. M., et al. (2002) · Science · doi:10.1126/science.1073733 · Cited by 803
“Scaffold-Hopping” by Topological Pharmacophore Search: A Contribution to Virtual Screening
Schneider, G., Neidhart, W., Giller, T., & Schmid, G. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19991004)38:19<2894::aid-anie2894>3.0.co;2-f · Cited by 717
Yoshida, M., Horinouchi, S., & Beppu, T. (1995) · BioEssays · doi:10.1002/bies.950170510 · Cited by 713
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
Pommier, Y. (2009) · Chemical Reviews · doi:10.1021/cr900097c · Cited by 707
Physicochemical Properties of Antibacterial Compounds: Implications for Drug Discovery
O’Shea, R., & Moser, H. E. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm700967e · Cited by 689
OMURA, S., IWAI, Y., HIRANO, A., NAKAGAWA, A., AWAYA, J., TSUCHIYA, H., TAKAHASHI, Y., & ASUMA, R. (1977) · The Journal of Antibiotics · doi:10.7164/antibiotics.30.275 · Cited by 674
Antibacterial Natural Products in Medicinal Chemistry—Exodus or Revival?
von Nussbaum, F., Brands, M., Hinzen, B., Weigand, S., & Häbich, D. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600350 · Cited by 672
Splicing factor SF3b as a target of the antitumor natural product pladienolide
Kotake, Y., Sagane, K., Owa, T., Mimori-Kiyosue, Y., Shimizu, H., Uesugi, M., Ishihama, Y., Iwata, M., & Mizui, Y. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.16 · Cited by 657
Isolation and structure of bryostatin 1
Pettit, G. R., Herald, C. L., Doubek, D. L., Herald, D. L., Arnold, E., & Clardy, J. (1982) · Journal of the American Chemical Society · doi:10.1021/ja00388a092 · Cited by 653
A New Golden Age of Natural Products Drug Discovery
Shen, B. (2015) · Cell · doi:10.1016/j.cell.2015.11.031 · Cited by 635
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor
Changelian, P. S., Flanagan, M. E., Ball, D. J., Kent, C. R., Magnuson, K. S., Martin, W. H., Rizzuti, B. J., Sawyer, P. S., Perry, B. D., Brissette, W. H., et al. (2003) · Science · doi:10.1126/science.1087061 · Cited by 607
Natural product and natural product derived drugs in clinical trials
Butler, M. S., Robertson, A. A. B., & Cooper, M. A. (2014) · Nat. Prod. Rep. · doi:10.1039/c4np00064a · Cited by 602
Koch, M. A., Schuffenhauer, A., Scheck, M., Wetzel, S., Casaulta, M., Odermatt, A., Ertl, P., & Waldmann, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503647102 · Cited by 544
The Application of Multi-Component Reactions in Drug Discovery
Weber, L. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023368719 · Cited by 534
Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9
Greiner, D., Bonaldi, T., Eskeland, R., Roemer, E., & Imhof, A. (2005) · Nature Chemical Biology · doi:10.1038/nchembio721 · Cited by 521
Halichondrins-antitumor polyether macrolides from a marine sponge
Hirata, Y., & Uemura, D. (1986) · Pure and Applied Chemistry · doi:10.1351/pac198658050701 · Cited by 519
Multidrug Resistance: Retrospect and Prospects in Anti-Cancer Drug Treatment
Perez-Tomas, R. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706777585077 · Cited by 509
Wetzel, S., Bon, R. S., Kumar, K., & Waldmann, H. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201007004 · Cited by 505
Rinehart, K. L., Holt, T. G., Fregeau, N. L., Stroh, J. G., Keifer, P. A., Sun, F., Li, L. H., & Martin, D. G. (1990) · The Journal of Organic Chemistry · doi:10.1021/jo00302a007 · Cited by 492
Towle, M. J., Salvato, K. A., Budrow, J., Wels, B. F., Kuznetsov, G., Aalfs, K. K., Welsh, S., Zheng, W., Seletsky, B. M., Palme, M. H., et al. (2001) · PubMed · Cited by 483
The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis
Dahmane, N., Sánchez, P., Gitton, Y., Palma, V., Sun, T., Beyna, M., Weiner, H., & Ruiz i Altaba, A. (2001) · Development · doi:10.1242/dev.128.24.5201 · Cited by 479
Breinbauer, R., Vetter, I. R., & Waldmann, H. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020816)41:16<2878::aid-anie2878>3.0.co;2-b · Cited by 475
The biosynthesis of peptidoglycan lipid-linked intermediates
Bouhss, A., Trunkfield, A. E., Bugg, T. D. H., & Mengin-Lecreulx, D. (2008) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2007.00089.x · Cited by 446
Taori, K., Paul, V. J., & Luesch, H. (2008) · Journal of the American Chemical Society · doi:10.1021/ja7110064 · Cited by 428
A potent cyclic hexapeptide analogue of somatostatin
Veber, D. F., Freidinger, R. M., Perlow, D. S., Paleveda, W. J., Holly, F. W., Strachan, R. G., Nutt, R. F., Arison, B. H., Homnick, C., Randall, W. C., et al. (1981) · Nature · doi:10.1038/292055a0 · Cited by 418
Finding the sweet spot: the role of nature and nurture in medicinal chemistry
Hann, M. M., & Keserü, G. M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3701 · Cited by 411
Total synthesis of halichondrin B and norhalichondrin B
Aicher, T. D., Buszek, K. R., Fang, F. G., Forsyth, C. J., Jung, S. H., Kishi, Y., Matelich, M. C., Scola, P. M., Spero, D. M., & Yoon, S. K. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00034a086 · Cited by 400
Small Molecule Natural Products in the Discovery of Therapeutic Agents: The Synthesis Connection
Wilson, R. M., & Danishefsky, S. J. (2006) · The Journal of Organic Chemistry · doi:10.1021/jo0610053 · Cited by 387
Bai, R. L., Paull, K. D., Herald, C. L., Malspeis, L., Pettit, G. R., & Hamel, E. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98491-7 · Cited by 379
Classification of scaffold-hopping approaches
Sun, H., Tawa, G., & Wallqvist, A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.10.024 · Cited by 375
The Scaffold Tree − Visualization of the Scaffold Universe by Hierarchical Scaffold Classification
Schuffenhauer, A., Ertl, P., Roggo, S., Wetzel, S., Koch, M. A., & Waldmann, H. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci600338x · Cited by 364
Molecular obesity, potency and other addictions in drug discovery
Hann, M. M. (2011) · MedChemComm · doi:10.1039/c1md00017a · Cited by 363
Natural withanolides: an overview
Chen, L.-X., He, H., & Qiu, F. (2011) · Natural Product Reports · doi:10.1039/c0np00045k · Cited by 358
Jirousek, M. R., Gillig, J. R., Gonzalez, C. M., Heath, W. F., McDonald, J. H., Neel, D. A., Rito, C. J., Singh, U., Stramm, L. E., Melikian-Badalian, A., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950588y · Cited by 339
Böhm, H.-J., Flohr, A., & Stahl, M. (2004) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2004.10.009 · Cited by 335
The modification of natural products for medical use
Guo, Z. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.06.003 · Cited by 328
Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.
Evans, B. E., Bock, M. G., Rittle, K. E., DiPardo, R. M., Whitter, W. L., Veber, D. F., Anderson, P. S., & Freidinger, R. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4918 · Cited by 327
Chang, R., Lotti, V., Monaghan, R., Birnbaum, J., Stapley, E., Goetz, M., Albers-Schonberg, G., Patchett, A., Liesch, J., Hensens, O., et al. (1985) · Science · doi:10.1126/science.2994227 · Cited by 319
Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis
Nören-Müller, A., Reis-Corrêa, I., Prinz, H., Rosenbaum, C., Saxena, K., Schwalbe, H. J., Vestweber, D., Cagna, G., Schunk, S., Schwarz, O., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601490103 · Cited by 303
Dynemicin A, a novel antibiotic with the anthraquinone and 1,5-diyn-3-ene subunit.
KONISHI, M., OHKUMA, H., MATSUMOTO, K., TSUNO, T., KAMEI, H., MIYAKI, T., OKI, T., KAWAGUCHI, H., VANDUYNE, G. D., & CLARDY, J. (1989) · The Journal of Antibiotics · doi:10.7164/antibiotics.42.1449 · Cited by 301
Aoki, S., Watanabe, Y., Sanagawa, M., Setiawan, A., Kotoku, N., & Kobayashi, M. (2006) · Journal of the American Chemical Society · doi:10.1021/ja057404h · Cited by 293
Norhalichondrin A: an antitumor polyether macrolide from a marine sponge
Uemura, D., Takahashi, K., Yamamoto, T., Katayama, C., Tanaka, J., Okumura, Y., & Hirata, Y. (1985) · Journal of the American Chemical Society · doi:10.1021/ja00302a042 · Cited by 289
Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65
Huang, X.-P., Karpiak, J., Kroeze, W. K., Zhu, H., Chen, X., Moy, S. S., Saddoris, K. A., Nikolova, V. D., Farrell, M. S., Wang, S., et al. (2015) · Nature · doi:10.1038/nature15699 · Cited by 284
Self-citationThe structural modification of natural products for novel drug discovery
Yao, H., Liu, J., Xu, S., Zhu, Z., & Xu, J. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1272757 · Cited by 275
Migrastatin analogues target fascin to block tumour metastasis
Chen, L., Yang, S., Jakoncic, J., Zhang, J. J., & Huang, X.-Y. (2010) · Nature · doi:10.1038/nature08978 · Cited by 268
Nicolaou, K. C., Hale, C. R. H., Nilewski, C., & Ioannidou, H. A. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35116a · Cited by 267
Cell-division inhibitors: new insights for future antibiotics
Lock, R. L., & Harry, E. J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2510 · Cited by 263
Antineoplastic agents. 257. Isolation and structure of spongistatin 1
Pettit, G. R., Chicacz, Z. A., Gao, F., Herald, C. L., Boyd, M. R., Schmidt, J. M., & Hooper, J. N. A. (1993) · The Journal of Organic Chemistry · doi:10.1021/jo00058a004 · Cited by 260
Chemistry and biology of natural and designed enediynes.
Nicolaou, K. C., Smith, A. L., & Yue, E. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.5881 · Cited by 258
Newlands, E., Rustin, G., & Brampton, M. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.415 · Cited by 248
Biology-Oriented Synthesis: Harnessing the Power of Evolution
van Hattum, H., & Waldmann, H. (2014) · Journal of the American Chemical Society · doi:10.1021/ja505861d · Cited by 245
Sanguinarine Blocks Cytokinesis in Bacteria by Inhibiting FtsZ Assembly and Bundling
Beuria, T. K., Santra, M. K., & Panda, D. (2005) · Biochemistry · doi:10.1021/bi050767+ · Cited by 236
Probing the Biology of Natural Products: Molecular Editing by Diverted Total Synthesis
Szpilman, A. M., & Carreira, E. M. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200904761 · Cited by 221
Staurosporine, a Potentially Important Gift from a Microorganism.
OMURA, S., SASAKI, Y., IWAI, Y., & TAKESHIMA, H. (1995) · The Journal of Antibiotics · doi:10.7164/antibiotics.48.535 · Cited by 216
Tam, S. W., Worcel, M., & Wyllie, M. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00156-5 · Cited by 209
Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates
Xiao, Z., Morris‐Natschke, S. L., & Lee, K. (2016) · Medicinal Research Reviews · doi:10.1002/med.21377 · Cited by 195
Nuclear export inhibition through covalent conjugation and hydrolysis of Leptomycin B by CRM1
Sun, Q., Carrasco, Y. P., Hu, Y., Guo, X., Mirzaei, H., MacMillan, J., & Chook, Y. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217203110 · Cited by 191
New natural products as new leads for antibacterial drug discovery
Brown, D. G., Lister, T., & May-Dracka, T. L. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.12.059 · Cited by 186
MIZUI, Y., SAKAI, T., IWATA, M., UENAKA, T., OKAMOTO, K., SHIMIZU, H., YAMORI, T., YOSHIMATSU, K., & ASADA, M. (2004) · The Journal of Antibiotics · doi:10.7164/antibiotics.57.188 · Cited by 185
Selectivity of Ligands for Opioid Receptors
Corbett, A. D., Paterson, S. J., & Kosterlitz, H. W. (1993) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-77460-7_26 · Cited by 184
Protein kinase C inhibitors as novel anticancer drugs
Jirousek, M. R., & Goekjian, P. G. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.12.2117 · Cited by 182
The many roles of molecular complexity in drug discovery
Méndez-Lucio, O., & Medina-Franco, J. L. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.08.009 · Cited by 180
Capturing Biological Activity in Natural Product Fragments by Chemical Synthesis
Crane, E. A., & Gademann, K. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201505863 · Cited by 177
Magedov, I. V., Manpadi, M., Ogasawara, M. A., Dhawan, A. S., Rogelj, S., Van slambrouck, S., Steelant, W. F. A., Evdokimov, N. M., Uglinskii, P. Y., Elias, E. M., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701499n · Cited by 173
Martinez, E. J., Owa, T., Schreiber, S. L., & Corey, E. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3496 · Cited by 170
Fusetani, N., Shinoda, K., & Matsunaga, S. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00063a017 · Cited by 169
Role of natural product diversity in chemical biology
Hong, J. (2011) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2011.03.004 · Cited by 168
Njardarson, J. T., Gaul, C., Shan, D., Huang, X.-Y., & Danishefsky, S. J. (2004) · Journal of the American Chemical Society · doi:10.1021/ja039714a · Cited by 166
Design and synthesis of analogues of natural products
Maier, M. E. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob00169b · Cited by 166
Caprazamycin B, a Novel Anti-tuberculosis Antibiotic, from Streptomyces sp.
Igarashi, M., NAKAGAWA, N., Doi, N., Hattori, S., NAGANAWA, H., & HAMADA, M. (2003) · The Journal of Antibiotics · doi:10.7164/antibiotics.56.580 · Cited by 165
Inhibition of Topoisomerase (DNA) I (TOP1): DNA Damage Repair and Anticancer Therapy
Xu, Y., & Her, C. (2015) · Biomolecules · doi:10.3390/biom5031652 · Cited by 164
Paclitaxel And Docetaxel Resistance: Molecular Mechanisms and Development of New Generation Taxanes
Galletti, E., Magnani, M., Renzulli, M. L., & Botta, M. (2007) · ChemMedChem · doi:10.1002/cmdc.200600308 · Cited by 164
Altohyrtin A, a potent anti-tumor macrolide from the Okinawan marine sponge Hyrtios altum
Kobayashi, M., Aoki, S., Sakai, H., Kawazoe, K., Kihara, N., Sasaki, T., & Kitagawa, I. (1993) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)73564-7 · Cited by 163
Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice
Shan, D., Chen, L., Njardarson, J. T., Gaul, C., Ma, X., Danishefsky, S. J., & Huang, X.-Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500658102 · Cited by 163
Macrocyclic ketone analogues of halichondrin B
Zheng, W., Seletsky, B. M., Palme, M. H., Lydon, P. J., Singer, L. A., Chase, C. E., Lemelin, C. A., Shen, Y., Davis, H., Tremblay, L., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.08.069 · Cited by 163
Recent advances in selective opioid receptor agonists and antagonists
Eguchi, M. (2004) · Medicinal Research Reviews · doi:10.1002/med.10059 · Cited by 163
Total Synthesis of Bryostatin 1
Keck, G. E., Poudel, Y. B., Cummins, T. J., Rudra, A., & Covel, J. A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja110198y · Cited by 162
Bever, W. F. M. V., Niemegeers, C. J. E., & Janssen, P. A. J. (1974) · Journal of Medicinal Chemistry · doi:10.1021/jm00256a003 · Cited by 161
Novel cytotoxic compounds from the ascidian Lissoclinum bistratum
Degnan, B. M., Hawkins, C. J., Lavin, M. F., McCaffrey, E. J., Parry, D. L., & Watters, D. J. (1989) · Journal of Medicinal Chemistry · doi:10.1021/jm00126a035 · Cited by 160
An Additive Definition of Molecular Complexity
Böttcher, T. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00723 · Cited by 160
Ōmura, S., Tomoda, H., Kim, Y. K., & NISHIDA, H. (1993) · The Journal of Antibiotics · doi:10.7164/antibiotics.46.1168 · Cited by 156
Cole, K. E., Dowling, D. P., Boone, M. A., Phillips, A. J., & Christianson, D. W. (2011) · Journal of the American Chemical Society · doi:10.1021/ja205972n · Cited by 153
Jackson, K. L., Henderson, J. A., & Phillips, A. J. (2009) · Chemical Reviews · doi:10.1021/cr900016w · Cited by 152
The Total Synthesis of (±)-Merrilactone A
Birman, V. B., & Danishefsky, S. J. (2002) · Journal of the American Chemical Society · doi:10.1021/ja012495d · Cited by 150
Boyd, M. R., Farina, C., Belfiore, P., Gagliardi, S., Kim, J. W., Hayakawa, Y., Beutler, J. A., McKee, T. C., Bowman, B. J., & Bowman, E. J. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29517-3 · Cited by 150
Sanglier, J., Quesniaux, V. F. J., FEHR, T., HOFMANN, H., Mahnke, M., Memmert, K., Schüler, W., Zenke, G., Gschwind, L., Maurer, C., et al. (1999) · The Journal of Antibiotics · doi:10.7164/antibiotics.52.466 · Cited by 149
Bouhss, A., Mengin‐Lecreulx, D., Beller, D. L., & van HEIJENOORT, J. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01623.x · Cited by 148
Lee, J., Hahm, E., & Singh, S. V. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq175 · Cited by 147
Sánchez‐Gómez, P., & Altaba, A. R. I. (2004) · Mechanisms of Development · doi:10.1016/j.mod.2004.10.002 · Cited by 146
Bugg, T. D. H., Lloyd, A. J., & Roper, D. I. (2006) · Infectious Disorders - Drug Targets · doi:10.2174/187152606784112128 · Cited by 144
Insights into drug discovery from natural products through structural modification
Chen, J., Li, W., Yao, H., & Xu, J. (2015) · Fitoterapia · doi:10.1016/j.fitote.2015.04.012 · Cited by 139
Identification of ACAT1- and ACAT2-specific inhibitors using a novel, cell-based fluorescence assay
Lada, A. T., Davis, M., Kent, C. R., et al. (2004) · Journal of Lipid Research · doi:10.1194/jlr.d300037-jlr200 · Cited by 136
Morphine, the Proteus of organic molecules
Blakemore, P. R., & White, J. D. (2002) · Chemical Communications · doi:10.1039/b111551k · Cited by 135
General Platform for Systematic Quantitative Evaluation of Small-Molecule Permeability in Bacteria
Davis, T. D., Gerry, C. J., & Tan, D. S. (2014) · ACS Chemical Biology · doi:10.1021/cb5003015 · Cited by 134
Crump, M., Leppä, S., Fayad, L., Lee, J. J., Rocco, A. D., Ogura, M., Hagberg, H., Schnell, F. M., Rifkin, R. M., Mackensen, A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.7171 · Cited by 134
Bai, R., Cichacz, Z. A., Herald, C. L., Pettit, G. R., & Hamel, E. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13253-7 · Cited by 127
Nakae, K., YOSHIMOTO, Y., SAWA, T., Homma, Y., HAMADA, M., TAKEUCH, T., & Imoto, M. (2000) · The Journal of Antibiotics · doi:10.7164/antibiotics.53.1130 · Cited by 120
Strategies for target identification of antimicrobial natural products
Farha, M. A., & Brown, E. D. (2016) · Natural Product Reports · doi:10.1039/c5np00127g · Cited by 119
Constituents of Withania somnifera Dun. III. The Side Chain of Withaferin A*,1
Lavie, D., Glotter, E., & Shvo, Y. (1965) · The Journal of Organic Chemistry · doi:10.1021/jo01017a015 · Cited by 117
Sedrani, R. C., Kallen, J., Cabrejas, L. M. M., Papageorgiou, C. D., Senia, F., Rohrbach, S., Wagner, D., Thai, B., Jutzi-Eme, A.-M., France, J., et al. (2003) · Journal of the American Chemical Society · doi:10.1021/ja021327y · Cited by 114
Target identification of natural products and bioactive compounds using affinity-based probes
Pan, S., Zhang, H., Wang, C., Yao, S. C. L., & Yao, S. Q. (2015) · Natural Product Reports · doi:10.1039/c5np00101c · Cited by 111
Huang, Y., Dong, G., Li, H., Liu, N., Zhang, W., & Sheng, C. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00393 · Cited by 111
Self-citationBonazzi, S., Eidam, O., Güttinger, S., Wach, J., Zemp, I., Kutay, U., & Gademann, K. (2010) · Journal of the American Chemical Society · doi:10.1021/ja9097093 · Cited by 109
FEHR, T., Kallen, J., Oberer, L., Sanglier, J., & SCHILLING, W. (1999) · The Journal of Antibiotics · doi:10.7164/antibiotics.52.474 · Cited by 108
Doodhi, H., Prota, A. E., Rodríguez-García, R., Xiao, H., Custar, D., Bargsten, K., Katrukha, E. A., Hilbert, M., Hua, S., Jiang, K., et al. (2016) · Current Biology · doi:10.1016/j.cub.2016.04.053 · Cited by 108
Chi, Y., Zhan, X., Hao, Y. U., Xie, G., Wang, Z., Xiao, W., Wang, Y., Xiong, F., Hu, J., Yang, L. C., et al. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20122582 · Cited by 107
Withanolides and Related Steroids
Misico, R. I., Nicotra, V. E., Oberti, J. C., Barboza, G. E., Gil, R. R., & Burton, G. (2011) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-7091-0748-5_3 · Cited by 107
Pettit, G. R., Cichacz, Z. A., Gao, F., Herald, C. L., & Boyd, M. R. (1993) · Journal of the Chemical Society Chemical Communications · doi:10.1039/c39930001166 · Cited by 106
Zenke, G., Strittmatter, U., Fuchs, S., Quesniaux, V. F. J., Brinkmann, V., Schüler, W., Zurini, M. G. M., Enz, A., Billich, A., Sanglier, J., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7165 · Cited by 105
Natural products as lead structures: chemical transformations to create lead-like libraries
Pascolutti, M., & Quinn, R. J. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.10.013 · Cited by 104
Caged Garcinia Xanthones: Development Since 1937
Han, Q., & Xu, H. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709789104993 · Cited by 104
Heel, R. C., Brogden, R. N., Speight, T. M., & Avery, G. S. (1978) · Drugs · doi:10.2165/00003495-197816060-00001 · Cited by 103
Bicyclol: A Novel Drug for Treating Chronic Viral Hepatitis B and C
Liu, G. (2009) · Medicinal Chemistry · doi:10.2174/157340609787049316 · Cited by 102
Simple compounds, 2-alkyl-2-amino-1,3-propanediols have potent immunosuppressive activity
Fujita, T., Yoneta, M., Hirose, R., Sasaki, S., Inoue, K., Kiuchi, M., Hirase, S., Adachi, K., Arita, M., & Chiba, K. (1995) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(95)00126-e · Cited by 101
Kunze, B., Reck, M., Dötsch, A., Lemme, A., Schummer, D., Irschik, H., Steinmetz, H., & Wagner‐Döbler, I. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-199 · Cited by 98
Target identification of biologically active small molecules via in situ methods
Su, Y., Ge, J., Zhu, B., Zheng, Y., Zhu, Q. X., & Yao, S. Q. (2013) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2013.06.005 · Cited by 97
Acyclic N-(azacycloalkyl)bisindolylmaleimides: isozyme selective inhibitors of PKCβ
Faul, M. M., Gillig, J. R., Jirousek, M. R., Ballas, L. M., Schotten, T., Kahl, A., & Mohr, M. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00286-5 · Cited by 93
Ii, K., Ichikawa, S., Al-Dabbagh, B., Bouhss, A., & Matsuda, A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100243n · Cited by 91
Butorphanol: Effects of a Prototypical Agonist-Antagonist Analgesic on κ-Opioid Receptors
Commiskey, S., Fan, L., Ho, I. K., & Rockhold, R. W. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.crj05001x · Cited by 87
Jessen, H. J., Schumacher, A., Shaw, T. W., Pfaltz, A., & Gademann, K. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201007671 · Cited by 87
Total Synthesis of (±)‐Merrilactone A
Chen, J., Gao, P., Yu, F., Yang, Y., Zhu, S., & Zhai, H. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201200378 · Cited by 87
Actin is the primary cellular receptor of bistramide A
Statsuk, A. V., Bai, R., Baryza, J. L., Verma, V. A., Hamel, E., Wender, P. A., & Kozmin, S. A. (2005) · Nature Chemical Biology · doi:10.1038/nchembio748 · Cited by 85
Antiviral Activity of Diterpene Esters on Chikungunya Virus and HIV Replication
Nothias-Scaglia, L.-F., Pannecouque, C. C., Renucci, F., Delang, L., Neyts, J. H., Roussi, F., Costa, J., Leyssen, P., Litaudon, M., & Paolini, J. (2015) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00073 · Cited by 85
Selectivity of Microbial Acyl-CoA : cholesterol Acyltransferase Inhibitors toward Isozymes
Ohshiro, T., Rudel, L. L., Ōmura, S., & Tomoda, H. (2007) · The Journal of Antibiotics · doi:10.1038/ja.2007.6 · Cited by 84
Construction of a microbial natural product library for chemical biology studies
Kato, N., Takahashi, S., Nogawa, T., Saito, T., & Osada, H. (2012) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2012.02.016 · Cited by 81
Evdokimov, N. M., slambrouck, S. V., Heffeter, P., Tu, L., Calvé, B. L., Lamoral‐Theys, D., Hooten, C., Uglinskii, P. Y., Rogelj, S., Robert Kiss, A., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1009428 · Cited by 78
Structure of Bistramide A−Actin Complex at a 1.35 Å Resolution
Rizvi, S. A., Tereshko, V. A., Kossiakoff, A. A., & Kozmin, S. A. (2006) · Journal of the American Chemical Society · doi:10.1021/ja058319c · Cited by 75
Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonists
Evans, B., Rittle, K. E., Bock, M. G., DiPardo, R. M., Freidinger, R. M., Whitter, W. L., GOULD, N. P., Lundell, G. F., & Homnick, C. F. (1987) · Journal of Medicinal Chemistry · doi:10.1021/jm00390a019 · Cited by 75
Function through Synthesis-Informed Design
Wender, P. A., Quiroz, R. V., & Stevens, M. C. (2015) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00004 · Cited by 74
Kellenberger, E., Hofmann, A., & Quinn, R. J. (2011) · Natural Product Reports · doi:10.1039/c1np00026h · Cited by 73
Kakeya, H. (2016) · Natural Product Reports · doi:10.1039/c5np00120j · Cited by 73
Li, W., Santos, P. E. L., Matthijs, S., Xie, G.-L., Busson, R. H., Cornélis, P., Rozenski, J., & Mot, R. D. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.08.006 · Cited by 71
Reck, M., Rutz, K., Kunze, B., Tomasch, J., Surapaneni, S., Schulz, S., & Wagner‐Döbler, I. (2011) · Journal of Bacteriology · doi:10.1128/jb.05424-11 · Cited by 71
Alonso, E., Fuwa, H., Vale, C., Suga, Y., Goto, T., Konno, Y., Sasaki, M., LaFerla, F. M., Vieytes, M. R., Giménez‐Llort, L., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja300565t · Cited by 69
Current Status on Marine Products with Reversal Effect on Cancer Multidrug Resistance
Abraham, I., Sayed, K. A. E., Chen, Z., & Guo, H. (2012) · Marine Drugs · doi:10.3390/md10102312 · Cited by 68
Óskarsson, T., Nagorny, P., Krauss, I. J., Pérez, L., Mandal, M., Yang, G., Ouerfelli, O., Xiao, D., Moore, M. A. S., Massagué, J., et al. (2010) · Journal of the American Chemical Society · doi:10.1021/ja9101503 · Cited by 65
Magedov, I. V., Frolova, L. V., Manpadi, M., Bhoga, U. D., Tang, H., Evdokimov, N. M., George, O., Georgiou, K. H., Renner, S., Getlik, M., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200410r · Cited by 65
Lagisetti, C., Yermolina, M. V., Sharma, L. K., Palacios, G. F., Prigaro, B. J., & Webb, T. R. (2013) · ACS Chemical Biology · doi:10.1021/cb400695j · Cited by 65
Stowell, J. C., Huot, R. I., & Voast, L. V. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00008a020 · Cited by 64
Švenda, J., Sheremet, M., Kremer, L., Maier, L., Bauer, J. O., Carsten Strohmann, B., Ziegler, S., Kumar, K., & Waldmann, H. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201500112 · Cited by 64
Jansen, R., Irschik, H., Hüch, V., Schummer, D., Steinmetz, H., Bock, M., Schmidt, T., Kirschning, A., & Müller, R. (2010) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200901126 · Cited by 62
Tsakos, M., Clement, L. L., Schaffert, E. S., Olsen, F. N., Rupiani, S., Djurhuus, R., Yu, W., Jacobsen, K. M., Villadsen, N. L., & Poulsen, T. B. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201509926 · Cited by 60
Rosenbaum, C., Baumhof, P., Mazitschek, R., Müller, O., Giannis, A., & Waldmann, H. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200352582 · Cited by 58
Total Synthesis of Carolacton, a Highly Potent Biofilm Inhibitor
Schmidt, T., & Kirschning, A. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201106762 · Cited by 57
Crestey, F., Jensen, A. A., Borch, M., Andreasen, J. T., Andersen, J., Balle, T., & Kristensen, J. L. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4013592 · Cited by 57
Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin A
Steadman, V. A., Pettit, S. B., Poullennec, K. G., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01329 · Cited by 55
Rakicidin A: A Hypoxia-Selective Cytotoxin
Yamazaki, Y. M., Kunimoto, S., & Ikeda, D. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.261 · Cited by 53
Design and Synthesis of Inhibitors of Hedgehog Signaling Based on the Alkaloid Cyclopamine
Winkler, J. D., Isaacs, A. K., Holderbaum, L., Tatard-Leitman, V. M., & Dahmane, N. (2009) · Organic Letters · doi:10.1021/ol900974u · Cited by 53
Fingolimod hydrochloride for the treatment of relapsing remitting multiple sclerosis
Thomas, K., Proschmann, U., & Ziemssen, T. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1373093 · Cited by 52
Kallen, J. A., Sedrani, R. C., Zenke, G., & Wagner, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501623200 · Cited by 51
Jiang, Z., Liu, N., Hu, D., Dong, G., Miao, Z., Yao, J., He, H., Jiang, Y., Zhang, W., Wang, Y., et al. (2015) · Chemical Communications · doi:10.1039/c5cc05699c · Cited by 50
Self-citationMolecular Determinants for Competitive Inhibition of α4β2 Nicotinic Acetylcholine Receptors
Iturriaga‐Vásquez, P., Carbone, A. L., García‐Beltrán, O., Livingstone, P. D., Biggin, P. C., Cassels, B. K., Wonnacott, S., Zapata‐Torres, G., & Bermúdez, I. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.065490 · Cited by 50
Roach, J. J., Sasano, Y., Schmid, C. L., Zaidi, S. A., Katritch, V., Stevens, R. C., Bohn, L., & Shenvi, R. A. (2017) · ACS Central Science · doi:10.1021/acscentsci.7b00488 · Cited by 50
1,4-Benzodiazepin-2-Ones in Medicinal Chemistry
Spencer, J., Rathnam, R. P., & Chowdhry, B. Z. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.226 · Cited by 49
Prezzavento, O., Arena, E., Sánchez–Fernández, C., Turnaturi, R., Parenti, C., Marrazzo, A., Catalano, R., Amata, E., Pasquinucci, L., & Cobos, E. J. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.077 · Cited by 49
Exploring and Exploiting Biologically Relevant Chemical Space
Eberhardt, L., Kumar, K. A., & Waldmann, H. (2011) · Current Drug Targets · doi:10.2174/138945011798109482 · Cited by 46
Donoghue, M. B., Lemery, S. J., Yuan, W., He, K., Sridhara, R., Shord, S. S., Zhao, H., Marathe, A., Kotch, L. E., Jee, J. M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2149 · Cited by 45
Fujishiro, S., Dodo, K., Iwasa, E., Teng, Y., Sohtome, Y., Hamashima, Y., Ito, A., Yoshida, M., & Sodeoka, M. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.11.087 · Cited by 43
Levorphanol use: past, present and future
Gudin, J. A., Fudin, J., & Nalamachu, S. R. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2016.1128308 · Cited by 43
Pyridone and Tetramic Acid Alkaloids from the Spider Pathogenic Fungus Torrubiella sp. BCC 2165
Isaka, M., Chinthanom, P., Supothina, S., Tobwor, P., & Hywel‐Jones, N. L. (2010) · Journal of Natural Products · doi:10.1021/np100492j · Cited by 42
Rakicidin A effectively induces apoptosis in hypoxia adapted Bcr‐Abl positive leukemic cells
Takeuchi, M., Ashihara, E., Yamazaki, Y. M., Kimura, S. H., Nakagawa, Y., Tanaka, R., Yao, H., Nagao, R., Hayashi, Y., Hirai, H., et al. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01813.x · Cited by 41
Total Synthesis and Biological Investigation of (−)-Promysalin
Steele, A. D., Knouse, K. W., Keohane, C. E., & Wuest, W. M. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b04767 · Cited by 41
Potent and Orally Efficacious Bisthiazole-Based Histone Deacetylase Inhibitors
Chen, F., Chai, H., Su, M., Zhang, Y., Li, J. X., Xie, X., & Nan, F. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400470s · Cited by 40
Total synthesis of pyripyropene A
Odani, A., Ishihara, K., Ohtawa, M., et al. (2011) · Tetrahedron · doi:10.1016/j.tet.2011.06.084 · Cited by 40
Hayakawa, Y., Sohda, K., Shin‐ya, K., Hidaka, T., & Seto, H. (1995) · The Journal of Antibiotics · doi:10.7164/antibiotics.48.954 · Cited by 40
ACAT inhibitors: evolution from cholesterol-absorption inhibitors to antiatherosclerotic agents
Roth, B. D. (1998) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01123-9 · Cited by 40
Synthesis of a Pladienolide B Analogue with the Fully Functionalized Core Structure
Müller, S., Mayer, T., Sasse, F., & Maier, M. E. (2011) · Organic Letters · doi:10.1021/ol201464m · Cited by 40
Compound high-quality criteria: a new vision to guide the development of drugs, current situation
Mignani, S. M., Huber, S., Tomás, H., Rodrigues, J., & Majoral, J. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.005 · Cited by 39
Sun, H., Yu, L.-H., Wei, H., & Liu, G.-T. (2012) · BioMed Research International · doi:10.1155/2012/584728 · Cited by 38
Lotti, V. J., Cerino, D. J., Kling, P. J., & Chang, R. S. L. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90159-1 · Cited by 35
Wender, P. A., Nakagawa, Y., Near, K. E., & Staveness, D. (2014) · Organic Letters · doi:10.1021/ol502491f · Cited by 32
Solinski, A. E., Koval, A. B., Brzozowski, R. S., Morrison, K. R., Fraboni, A. J., Carson, C. E., Eshraghi, A. R., Zhou, G., Quivey, R. G., Voelz, V. A., et al. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b03879 · Cited by 32
Steele, A. D., Keohane, C. E., Knouse, K. W., Rossiter, S. E., Williams, S. J., & Wuest, W. M. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b03373 · Cited by 31
Stabilized Cyclopropane Analogs of the Splicing Inhibitor FD-895
Villa, R., Kashyap, M. K., Kumar, D., Kipps, T. J., Castro, J. E., Clair, J. J. L., & Burkart, M. D. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400861t · Cited by 29
Cited by
Overcoming cancer therapeutic bottleneck by drug repurposing
Zhang, Z., Zhou, L., Xie, N., Nice, E. C., Zhang, T., Cui, Y., & Huang, C. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00213-8 · Cited by 516
An overview of spirooxindole as a promising scaffold for novel drug discovery
Zhou, L.-M., Qu, R.-Y., & Yang, G.-F. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1733526 · Cited by 316
Metadata
- Authors
- Wang, S., Dong, G., & Sheng, C.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2019-02-07
- Volume
- 119
- Issue
- 6
- Pages
- 4180-4220
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2913789599
- Cited by
- 254
- References
- 215
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.